story of the week
Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease
N. Engl. J. Med 2020 Dec 05;[EPub Ahead of Print], EB Esrick, LE Lehmann, A Biffi, M Achebe, C Brendel, MF Ciuculescu, H Daley, B MacKinnon, E Morris, A Federico, D Abriss, K Boardman, R Khelladi, K Shaw, H Negre, O Negre, S Nikiforow, J Ritz, SY Pai, WB London, C Dansereau, MM Heeney, M Armant, JP Manis, DA WilliamsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.